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hristoph Kalka, MD
üsseldorf, Germany
OBJECTIVES We investigated whether human age-related endothelial dysfunction is accompanied by
quantitative and qualitative alterations of the endothelial progenitor cell (EPC) pool.
BACKGROUND Circulating progenitor cells with an endothelial phenotype contribute to the regeneration and
repair of the vessel wall. An association between the loss of endothelial integrity and EPC
modification may provide a background to study the mechanistic nature of such age-related
vascular changes.
METHODS In 20 old and young healthy individuals (61  2 years and 25  1 year, respectively) without
major cardiovascular risk factors, endothelial function, defined by flow-mediated dilation of
the brachial artery via ultrasound, as well as the number and function of EPCs isolated from
peripheral blood, were determined.
RESULTS Older subjects had significantly impaired endothelium-dependent dilation of brachial artery
(flow-mediated dilation [FMD] 5.2  0.5% vs. 7.1  0.6%; p  0.05). Endothelium-
independent dilation after glycerol trinitrate (GTN) was not different, but the FMD/GTN
ratio was significantly lower in old subjects (49  4% vs. 37  3%; p  0.05), suggesting
endothelial dysfunction. There were no differences in the numbers of circulating EPCs,
defined as CD34/KDR or CD133/KDR double-positive cells in peripheral blood. In contrast,
lower survival (39  6 cells/mm2 vs. 65  11 cells/mm2; p  0.05), migration (80  12 vs.
157  16 cells/mm2; p  0.01), and proliferation (0.20  0.04 cpm vs. 0.44  0.07 cpm; p 
0.05) implicate functional impairment of EPCs from old subjects. The FMD correlated
univariately with EPC migration (r  0.52, p  0.05) and EPC proliferation (r  0.49, p 
0.05). Multivariate analysis showed that both functional features represent independent
predictors of endothelial function.
CONCLUSIONS Maintenance of vascular homeostasis by EPCs may be attenuated with age based on
functional deficits rather than depletion of CD34/KDR or CD133/KDR cells. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.074Cardiol 2005;45:1441–8) © 2005 by the American College of Cardiology Foundation
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che functional integrity of the endothelial monolayer is
ssential to prevent vascular leakage in response to local
njuries and to protect against the initiation of atherogenesis
1,2). Marked changes in the endothelial morphology in-
lude a loss of the orientation of endothelial cells in the
See page 1458
irection of the blood flow, decreased overlap between
djacent endothelial cells, and an accelerated turnover of
ndothelial cells in response to continuous injury, such as
yperlipidemia, hypertension, and mechanical stress (3). It
as been proposed that this kind of disruption of vascular
omeostasis predisposes the vessel wall to vasoconstriction,
eukocyte adherence, platelet adhesion, thrombosis, vascular
nflammation, and eventually atherosclerotic lesion formation.
From the Department of Cardiology, Pneumology, and Vascular Medicine,
einrich-Heine-University, Düsseldorf, Germany. This study was supported by the
eutsche Forschungsgemeinschaft (SFB612 to Dr. Kalka and Dr. Kelm). The first
wo authors contributed equally to this study. Dr. Heiss is currently affiliated with the
ivision of Cardiology, University of California, San Francisco, San Francisco,
alifornia.a
Manuscript received July 12, 2004; revised manuscript received November 29,
004, accepted December 6, 2004.Among the risk factors for atherosclerosis, aging is a
ignificant predictor of impairment of endothelium-dependent
asodilation (4,5). Experimental and clinical research has
emonstrated an increased risk of atherosclerotic disease
nd poor outcomes in older patients as compared with their
ounger counterparts (6). Furthermore, it has been sug-
ested that senescent changes in the cardiovascular system
ay predispose older individuals to increased cardiovascular
athology (7). This suggests that aging is associated with an
ndogenous alteration of the vessel wall promoting athero-
clerosis and vascular dysfunction (8,9).
Although the mechanism for the age-related endothelial
ysfunction is not known, the effect of endothelial turnover
nd regeneration is likely to be involved in the dysfunction
10). Recent studies suggest that besides surrounding ma-
ure endothelial cells, bone marrow-derived endothelial
rogenitor cells (EPCs) may play a critical role in maintain-
ng endothelial function in mature blood vessels by contrib-
ting to re-endothelialization and neovascularization (11,12).
t is therefore conceivable that any impairment of this
asculogenic element to endothelial regeneration may ac-
ount for the progression of endothelial dysfunction and
therosclerosis (13).
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Progenitor Cell and Vascular Dysfunction With Age May 3, 2005:1441–8Extending recent studies showing a reduction of the
umber and migratory activity in patients with coronary
rtery disease and a negative correlation of the number of
PC colony-forming units with the Framingham cardio-
ascular risk factor score (14–17), we focused on the
uestion of whether the sole phenotype aging without
pparent cardiovascular disease is associated with a de-
line in the number and/or function of vascular stem and
rogenitor cells. We hypothesized that possible age-
elated alterations in progenitor cell number and function
orrelate directly with the degree of senescent endothelial
ysfunction.
ETHODS
tudy subjects. We studied 20 young (25 1 year) and 20
ld (61  2 years) healthy subjects without clinical evidence
f other cardiovascular risk factors. All subjects were asymp-
omatic, normotensive (as defined by systolic blood pressure
140 mm Hg and diastolic blood pressure 90 mm Hg),
ondiabetic (as defined by fasting glucose levels 126
g/dl), normocholesteremic (as defined by total cholesterol
evels 240 mg/dl and low-density lipoprotein [LDL]
holesterol levels 160 mg/dl), and nonsmokers (18–21).
hey had no significant medical history and were not taking
egular or incidental medication, including hormonal con-
raception. All older female subjects were postmenopausal.
o other menstrual cycle history was taken. The clinical
haracteristics are summarized in Table 1. Informed consent
as obtained from all study subjects before enrollment. The
Abbreviations and Acronyms
EPC  endothelial progenitor cell
FACS  fluorescence-activated cell sorting
FBS  fetal bovine serum
FMD  flow-mediated dilation
GTN  glycerol trinitrate
KDR  kinase insert domain-containing receptor
(human VEGF receptor-2)
MNC  peripheral blood mononuclear cell
UEA-1  Ulex europaeus agglutinin I
VEGF  vascular endothelial growth factor
Table 1. Baseline Clinical Characteristics of St
Characteristics Young Subj
Age (yrs) 25
Men 10 (
Body mass index (kg/m2) 22
Systolic blood pressure (mm Hg) 117
Diastolic blood pressure (mm Hg) 77
LDL cholesterol (mg/dl) 133
HDL cholesterol (mg/dl) 70
Triglyercides (mg/dl) 87
Glucose (mg/dl) 88
CRP (mg/dl) 0.05Data are expressed as the mean value  SE or number (%) of sub
CRP  C-reactive protein; HDL and LDL  high- and low-tudy protocol was approved by the local ethics committee
f the Heinrich-Heine University of Düsseldorf.
etermination of endothelial function. Endothelium-
ependent dilation of the brachial artery was measured
oninvasively by high-resolution ultrasound (Sonos 5500,
gilent, with a 15-MHz linear-array transducer) using
tandard techniques (22–24). Briefly, baseline data for
iameter and mean blood flow velocity of the brachial artery
ere quantified after 10 min of supine rest in an air-
onditioned room (21°C) at 1 to 2 cm above the elbow. To
nduce ischemic dilation of resistive vessels, a blood pressure
uff was placed around the forearm distal to the cubital fossae
nd inflated to 200 mm Hg for a period of 5 min. Increased
lood flow and shear stress during hyperemia leads to NO-
ependent flow-mediated dilation (FMD) of the brachial
rtery. One minute after deflation of the cuff, the diameter was
easured again. Endothelium-independent dilation was quan-
ified 4 min after sublingual administration of 400 g glycerol
rinitrate (GTN; Pohl, Germany). All ultrasound scans were
erformed by the same operator using the same equipment.
n automated analysis system was used to measure diame-
ers (Brachial analyzer, Medical Imaging Applications, Iowa
ity, Iowa), yielding low variabilities of our methodology
escribed elsewhere (22).
Both FMD and endothelium-independent dilation were
xpressed as the percent change from baseline. To estimate
he relative proportion of FMD compared with the maxi-
ally achievable diameter after GTN, the FMD/GTN ratio
as calculated and expressed as a percentage for each
ndividual. Blood flow was calculated by multiplication of
ross-sectional area and mean velocity at each time point.
luorescence-activated cell sorting (FACS) for circulat-
ng EPCs. Blood samples were taken on the morning of
he ultrasound examination after a 14-h overnight fast to
easure the serum lipid profile and other biochemical param-
ters. Mononuclear cells (MNCs) were isolated from periph-
ral venous blood by density centrifugation (Histopaque-1077,
igma-Aldrich, Tuuflurchen, Germany). Freshly isolated
NCs were incubated for 30 min at 4°C in the dark with
onoclonal antibodies against human KDR (Sigma-
ldrich), followed by fluorescein isothiocyanate (FITC)-
onjugated rat anti-mouse secondary antibody (BD Bio-
Population
n  20) Old Subjects (n  20) p Value
61  2 0.001
7 (35%)
24  1 NS
122  3 NS
81  2 NS
142  6 NS
72  4 NS
97  8 NS
91  2 NS
3 0.15  0.08 NSudy
ects (
 1
50%)
 1
 2
 2
 5
 4
 10
 2
 0.0jects.
density lipoprotein, respectively; NS  not significant.
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May 3, 2005:1441–8 Progenitor Cell and Vascular Dysfunction With Ageciences, Franklin Lakes, New Jersey), with FITC- or
hycoerythrin-conjugated antibodies against human CD45
nd CD34 (Beckman-Coulter, Krefeld, Germany) and
D133 (Miltenyi Biotech, Bergisch Gladbach, Germany).
sotype-identical antibodies served as controls (BD Bio-
ciences). After incubation, cells were fixed with 1% para-
ormaldehyde, and quantitative analysis was performed on
PICS XL (Beckman Coulter) measuring 50,000 cells per
ample.
ell culture enrichment of EPCs. The EPC culture was
erformed as previously described (25). Briefly, MNCs (7.5
06) were plated on fibronectin-coated six-well culture
ishes and maintained in endothelial cell basal medium-2
EBM-2, Clonetics, San Diego, California) supplemented
ith EGM-2 microvascular single aliquots and 5% fetal
ovine serum (FBS). Adherent cells were passaged once at
ay 4, and the endothelial phenotype was confirmed by flow
ytometry (KDR, CD31, CD105, CD146) and immunohis-
ochemistry (von Willebrand factor, tie-2) on day 8 adherent
ells before measuring EPC migration and proliferation
25,34). A different protocol was used for the survival assay.
valuation of EPC survival. The MNCs (1  106) were
ultured in four-well glass slides in EBM-2 media supple-
ented with 100 ng/ml vascular endothelial growth factor
VEGF) protein (Chemicon, Temecula, California). After
our days, adherent cells of endothelial lineage were identi-
ed by the concurrent binding of FITC-conjugated Ulex
uropaeus agglutinin I (UEA-1, Sigma) and the uptake of
iI-labeled acetylated low-density lipoprotein (acLDL,
ellSystems, St. Katharinen, Germany). Two independent
nvestigators evaluated the number of EPCs per mm2 by
ounting dual-staining cells in 15 randomly selected high-
ower fields using an inverted fluorescent microscope (Ni-
on, Melville, New York).
roliferation assay. Proliferation was measured by a col-
rimetric assay that bases on the cleavage of tetrazolium
alts (WST-1) by mitochondrial dehydrogenase. After con-
rming expression of markers for endothelial lineage,
ulture-enriched EPCs (1  104 cells per well) were plated
n fibronectin-coated 96-well plates and cultured for 24 h.
fter another 48 h of starving with EBM-2 media with
.1% bovine serum albumin (BSA) (Sigma),WST-1 (TaKaRa
io, Otsu, Japan) was added, and absorbance at 440 nm was
easured with an ELISA reader.
igration assay. The migratory capacity of culture-
nriched EPCs expressing endothelial markers was deter-
ined using a modified Boyden chamber. A total of 4 104
PCs were resuspended in EBM-2 plus 0.1% BSA and
laced in the upper chamber. The lower chamber contained
BM-2 plus 50 ng/ml recombinant VEGF protein. After
h of incubation at 37°C, migrated cells on the lower side
f the fibronectin/vitronectin-coated filter (pore size 8 m,
euro Probe, Gaithersburg, Maryland) were fixed and
tained with Diff-Quick (Dade Behring, Liderbach, Ger-
any). For quantification, cells were counted manually in
ve random high-power fields. Klasma VEGF level. The level of VEGF in the blood
lasma of young and old subjects was measured by a
igh-sensitive ELISA assay (R&D Systems, Minneapolis,
innesota) according to the manufacturer’s instructions.
riefly, all VEGF standards and samples were placed into
ells coated with antibody specific for human VEGF. In a
econd step, a biotinylated antibody specific for VEGF was
dded to the wells. Afterward, the wells were incubated with
treptavidin-horseradish peroxidase and stained by incubation
ith a substrate solution. The absorbance of standards and
amples was measured at 450 nm with a microplate reader.
ll measurements were performed in triplicate.
tatistical analysis. Results are expressed as the mean
alue SE. Comparisons between groups were analyzed by
he Student t test. Univariate correlations were calculated
sing Pearson’s coefficient (r). To estimate the predictive
alue of EPC function in explaining variability of endothe-
ial function measured by FMD, a multivariate linear
egression analysis was performed, including established
arameters known to affect vascular function and progres-
ion of atherosclerosis. Standardized coefficients were cal-
ulated as a measure for the relative predictive value.
tatistical significance was assumed if a null hypothesis
ould be rejected at p  0.05. All analyses were performed
ith SPSS 11.0.1 (SPSS Inc., Chicago, Illinois).
ESULTS
tudy subjects. The baseline characteristics were within
ormal limits and not significantly different between old and
oung subjects (Table 1).
ndothelial dysfunction in aged individuals. Endothelial
unction measured by FMD was significantly impaired in
ld compared with young subjects (5.2  0.5% vs. 7.1 
.6%, p  0.05) (Fig. 1). Endothelium-independent dila-
ion in response to GTN was not significantly different
13.7  0.8% vs. 15.2  1.1%, p  NS). The FMD/GTN
atio was significantly smaller in old subjects (49  4% vs.
7  3%, p  0.05), suggesting selective endothelial
ysfunction with a preserved dilatory response of vessel wall
mooth muscle cells. The baseline diameter of the brachial
rtery was significantly smaller in young study subjects (4.2 
.1 mm vs. 3.7  0.2 mm, p  0.05). No significant
ifferences were seen in blood flow at baseline and during
yperemia (108 16 ml/min vs. 118 19 ml/min and 708
6 ml/min vs. 644  38 ml/min, each p  NS).
ffect of age on number of circulating EPCs. To inves-
igate whether age as a sole cardiovascular risk factor is
ssociated with quantitative changes in the circulating
ndothelial progenitor pool, we isolated MNCs from the
eripheral blood of 20 young and 20 old healthy volunteers
for patients characteristics, see Table 1) and used FACS
nalysis to determine the number of EPCs, considered to be
haracterized by the expression of KDR and CD34, in the
eripheral circulation. We also analyzed the expression
DR and CD133 to examine the number of a more
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Progenitor Cell and Vascular Dysfunction With Age May 3, 2005:1441–8mmature subset of progenitor cells. The total numbers per
illiliter of blood of both KDR/CD34 double-positive cells
nd KDR/CD133 double-positive cells were not signifi-
antly different between young and old subjects (KDR/
D34: 436  88 cells/ml vs. 505  88 cells/ml; KDR/
D133: 373  52 cells/ml vs. 391  68 cells/ml) (Fig. 2).
e did not observe a significant difference in the mean
uorescence intensity of the KDR receptor (data not shown).
Because our study population included male and female
olunteers, we also analyzed the data for gender-related
ifferences. However, there were no gender differences in
rogenitor cell numbers within and between both groups
data not shown).
ge-related impairment of EPC survival. To determine
he survival and differentiation potential of aged EPCs, we
pplied a culture assay plating identical numbers of MNCs
nd cultured the cells in endothelial media using a modified
EGF supplemented protocol. After four days of culture, a
educed number of EPCs, characterized by DiI-acLDL
igure 1. Endothelial dysfunction in old subjects. Whereas (A) flow-
ediated dilation (FMD) was significantly impaired in old subjects (n  20,
olid columns), (B) dilation after 400 g of sublingual glycerol-trinitrate
GTN) was not (n  20, open columns). (C) A decreased FMD/GTN
atio in the elder group implies specific endothelial dysfunction. Columns
re mean  SE.ptake and concomitant UEA-1 binding, were counted
c
mithin the old population (39  6 cells/mm2 vs. 65 
1 cells/mm2, p  0.05) (Fig. 3A).
unctional alterations of EPCs associated with aging. As
reviously reported, we used culture-enriched EPCs to
ssess functional differences of progenitors between young
nd old subjects. The endothelial phenotype was confirmed
y demonstrating the expression of KDR (83  8%), CD31
94 2%), CD105 (75 5%), and CD146 (65 7%) by flow
ytometry and by immunocytochemistry for von Willebrand
actor and tie-2 (data not shown) (25). We analyzed the
roliferatory and migratory capacity of EPCs as important
ellular features of progenitor cells (26). The proliferative
ctivity of EPCs was significantly reduced in old subjects
0.20  0.04 vs. 0.44  0.07, p  0.05) (Fig. 3B). Similarly,
he migratory response of EPCs toward a gradient of VEGF
as significantly reduced in old subjects as compared their
oung counterparts (80  12 cells/mm2 vs. 157  16
ells/mm2, p  0.01) (Fig. 3C). As implied earlier, this
ifference was not associated with a reduction of the
eceptor for VEGF, KDR, on EPCs.
PC function correlates with endothelium-dependent
ascular parameters. We showed a strong univariate cor-
elation between the level of endothelial function and
mportant functional cellular features of progenitor cells.
oth the proliferatory activity and the migratory capacity of
PCs correlated significantly with the FMD (r 0.49, p
.05; r  0.52, p  0.01) (Figs. 4A and 4B).
igure 2. Concentrations of endothelial progenitor cells in old and young
ubjects. Neither the concentration of (A) KDR/CD133 or (B) KDR/
D34 cells was significantly different between old (n  20, open
olumns) and young subjects (n 20, solid columns). Columns represent
ean values, error bars are the standard error; p  0.05.
P
k
m
i
c
i
v
I
t
m
r
t
g
a
m
i
E
a
R
D
A
e
d
i
(
f
c
a
t
b
V
w
E
i
t
(
d
p
a
c
t
a
o
f
w
s
i
l
w
d
P
r
d
p
t
p
t
b
c
s
d
e
i
i
p
p
f
a
a
m
F
i
r
s
b
1445JACC Vol. 45, No. 9, 2005 Heiss et al.
May 3, 2005:1441–8 Progenitor Cell and Vascular Dysfunction With Agelasma VEGF level. To determine changes in the cyto-
ine or growth factor setting associated with aging, we
easured the expression level of VEGF, which is an
mportant regulator of EPC recruitment. The VEGF con-
entration in the peripheral blood were significantly higher
n old as compared with young subjects (93.7  5.6 pg/ml
s. 61.4  3.8 pg/ml, p  0.001).
ndependent predictors of endothelial function. In order
o identify independent predictors for endothelial function
easured by FMD, we performed a multivariate linear
egression analysis, including baseline characteristics known
o affect vascular function (age, gender, LDL, plasma
lucose, C-reactive protein, baseline diameter of brachial
rtery, VEGF) and parameters of EPC function (survival,
igration, proliferation). As shown in Table 2, the only
ndependent predictors for FMD were EPC proliferation,
PC migration, and baseline diameter of brachial artery,
ccounting for 53% of the total variability of FMD (adjusted
igure 3. The endothelial progenitor cell (EPC) function in old and young
ndividuals. (A) EPC survival, (B) proliferation, and (C) migration are
educed in old (n  20, open columns) as compared with young study
ubjects (n  20, solid columns). Columns represent mean values, error
ars are the standard error.2  0.528, p  0.001). aISCUSSION
ging stem cells may play a critical role in determining the
ffects of aging on organ function. With regard to vascular
iseases, it has been postulated that circulating EPCs are
nvolved in the repair mechanisms after endothelial damage
27,28). Ultimately, deterioration of endothelial or vascular
unction may be related to both quantitative and qualitative
hanges of stem cells.
We describe here the first comprehensive analysis of the
ssociation between age-related endothelial dysfunction and
he number and function of circulating EPCs, defined
y expression of CD34/VEGFR2 and CD133/
EGFR2. Although no quantitative differences in EPCs
ere observed, our data illustrate that culture-enriched
PCs from old but otherwise healthy subjects are impaired
n terms of fundamental functional features like prolifera-
ion (important for amplifying the cellular pool), migration
critical for homing of circulating EPCs), and survival. We
emonstrate a significant univariate correlation between the
roliferative and migratory capacity of EPCs and FMD. In
multivariate model, both functional features of progenitor
ells represent independent predictors of endothelial func-
ion, indicating that abnormalities in EPC function may
ccount for the impaired vascular regeneration and repair
bserved in the old.
Elderly individuals showed endothelium-specific dys-
unction of vascular reactivity, indicated by impaired FMD
ith preserved endothelium-independent dilation, and a
ignificantly lowered FMD/GTN ratio. In order to specif-
cally investigate the effect of aging on EPCs and endothe-
ial function, major cardiovascular risk factors associated
ith endothelial dysfunction, hypertension, hyperlipidemia,
iabetes mellitus, and cigarette smoking were excluded.
lasma glucose, LDL cholesterol, blood pressure, C-
eactive protein, and body mass index were not significantly
ifferent between old and young subjects and were not inde-
endent predictors of FMD in the multivariate analysis. Other
han EPC migration and proliferation, the only independent
redictor of endothelial function was the baseline diameter of
he brachial artery. The greater baseline diameter of the
rachial artery, reported to inversely correlate with FMD (29),
an therefore at least in part account for a lower FMD in older
ubjects. In fact, the standardized coefficient for baseline
iameter was comparable to the sum of migration and prolif-
ration coefficients indicating a similar magnitude of association.
Changes in stem and progenitor cells may be of great
mportance for the aging process, because any decline with age
n the numbers and functional integrity of stem cells could
otentially lead to progressive deterioration of functional and
roliferative homeostasis in organs (30). Current explanations
or impaired neovascularization or re-endothelialization with
ge have involved the conventional paradigm of angiogenesis
nd focused on alterations in mature endothelial cells and
onocytes. Senescent changes in endothelial function are
ccompanied by changes in angiogenic activity and alterations
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Progenitor Cell and Vascular Dysfunction With Age May 3, 2005:1441–8n growth factor expression (10,31), indicating that in the old,
ocal endothelial cells are not capable of reacting to various
orms of vessel wall injury in response to excessive and
nflammatory/proliferatory processes.
Recent studies support the notion that one plausible
echanism for the vascular changes in advancing aging is
he exhaustion of cells, in particular, bone marrow cells that
re capable of vascular repair (13,32). Exhaustion of this
omponent of bone marrow in number, function, or both
ould produce disequilibrium between vascular injury and
ascular repair, which leads to atherosclerosis (2,33). In-
eed, several studies demonstrated that the number of
irculating EPCs inversely correlated with risk factors for
oronary artery disease, such as smoking, family history of
oronary artery disease, hypertension (34), and diabetes
ellitus (35). Interestingly, our study did not reveal a
ignificant difference in the total number of circulating stem
ells and the progenitor pool between old and young
ersons. Rather, we found an increased percentage of
D34/KDR cells in old individuals. However, due to
he decrease in the number of mononuclear cells in the older
ubjects, the total number of circulating stem cells was not
ignificantly different. Together with the data revealing a
ignificantly higher VEGF plasma level and reduced EPC
urvival in the elderly, this may reflect the attempt of the
ged organism to mobilize vascular stem and progenitor
ells into the peripheral blood in response to endothelial
ysfunction at an early stage of atherosclerosis. It also
uggests that greater stimulation is required to maintain the
irculating numbers of progenitor cells in the circulation. A
ecreased number of other cells that are potential sources of
utative endothelial cells (e.g., CD34/CD14 mono-
ytes) cannot be excluded (36,37).
It is conceivable that aging is associated with dysfunc-
ional progenitor cells and defective vasculogenesis. Prelim-
igure 4. Correlations of endothelial function and endothelial progenitor
roliferation (r  0.49, p  0.05) and (B) migration (r  0.52, p  0.01nary results from animal studies indicated that transplan-
p
Vation of bone marrow (including EPCs) from old mice into
oung mice led to minimal neovascularization relative to
ransplantation of young bone marrow (38). It was also
emonstrated that EPCs from older patients with clinical
schemia had a significantly less therapeutic effect in rescu-
ng ischemic hindlimb of nude mice compared with those
rom younger ischemic patients (38,39). These studies
rovide evidence to support an age-dependent impairment
n neovascularization that is heavily influenced by the EPC
henotype. In accordance with these and other data, our
esults show that aging as a sole cardiovascular risk factor is
ssociated with diminished fundamental functional features
f progenitor cells. Thus, beyond impaired EPC mobiliza-
ion, the activity of progenitor cells in response to tissue
njury may contribute to the age-dependent defect in
ostnatal re-endothelialization and neovascularization. As a
ritical point, it has to be noted that the results of functional
ssays are based on ex vivo expanded EPCs and do not
PC) function. Flow-mediated dilation (FMD) correlated with (A) EPC
en circles  old subjects; solid circles  young subjects.
able 2. Multivariate Linear Regression Analysis
FMD
Standard Coefficient p Value
ge 0.205 0.242
ender 0.308 0.110
DL 0.054 0.663
lasma glucose 0.145 0.243
RP 0.078 0.540
iameter brachial artery 0.755 0.001
PC survival 0.043 0.740
PC migration 0.342 0.015
PC proliferation 0.429 0.002
EGF 0.095 0.470
djusted R2 0.528
ignificance (ANOVA) 0.001
old entries indicate significant p values.
ANOVA  analysis of variance; CRP  C-reactive protein; EPC  endothelialrogenitor cell; FMD  flow-mediated dilation; LDL  low-density lipoprotein;
EGF  vascular endothelial growth factor.
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May 3, 2005:1441–8 Progenitor Cell and Vascular Dysfunction With Ageecessarily reflect the potential of primitive cells present in
he human circulation. Other factors (i.e., reduced adhe-
ion) may lead to a different selection of cells during culture.
Recently, Hill et al. (16) described the correlation be-
ween the number of EPC colonies after one week of
ulture, as an equivalent for the level of circulating EPCs,
ith the brachial artery reactivity as an index of endothelial
unction. It was concluded that the quantity of EPCs
rovides a useful index of cumulative cardiovascular risk and
ascular function in subjects with various degrees of cardio-
ascular risk. Focusing on age as an isolated risk factor, we
how correlations between endothelial function and EPC
unctions as measured after culture expansion but not
irculating EPC numbers as measured by expression of
D34/VEGFR2 and CD133/VEGFR2 in periph-
ral blood. We argue that these results are in line with the
ndings of Hill et al. The number of EPC colonies is not
nly dependent on the number of EPCs used for the assay,
ut most importantly relies on the proliferatory capacity,
dhesion, and survival of cells during culture. Therefore, we
eason that functional rather than numeric changes of
ertain vascular progenitor cells may be responsible for
ge-related conditions. Increased VEGF levels may com-
ensatorily mobilize EPCs, explaining similar EPC num-
ers despite lower survival. However, multivariate analysis
howed that proliferation and migration of EPCs represent
ndependent predictors of endothelial function, indicating a
egenerative role of EPCs in early rather than late stages of
ascular damage.
The continuous circulation of vascular stem and progen-
tor cells may provide a hemeostatic means of meeting the
tem cell crisis in response to stress or organ injury. This
ind of vascular repair mechanism is critical for maintaining
rgan viability in a setting of impaired blood flow or hemo-
tatic disruption. Understanding senescence-associated
hanges in vascular function, as well as the role that cells with
egenerative potential play in modulating vascular reactivity,
ill be important for the development of more effective
herapies for the prevention and treatment of cardiovascular
isease in older individuals.
cknowledgment
he authors thank Simone Matern for technical assistance.
eprint requests and correspondence: Dr. Christoph Kalka,
epartment of Cardiology, Pneumology and Vascular Medicine,
einrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf,
ermany. E-mail: kalka-moll@web.de.
EFERENCES
1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:
791–804.
2. Lusis AJ. Atherosclerosis. Nature 2000;407:233–41.
3. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol
Cell Cardiol 1999;31:23–37.
4. Castelli WP. Epidemiology of coronary heart disease: the Framingham
study. Am J Med 1984;76:4–12.5. Weinsaft JW, Edelberg JM. Aging-associated changes in vascular
activity: a potential link to geriatric cardiovascular disease. Am J
Geriatr Cardiol 2001;10:348–54.
6. Kannel WB, Gordon T. Cardiovascular risk factors in the aged: the
Framingham study. In: Haynes SG, Feinleib M, editors. Epidemi-
ology of Aging. Bethesda, MD: National Institutes of Health,
1980:65–98.
7. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age.
Physiol Rev 1993;73:413–67.
8. Gerhard M, Roddy M-A, Creager SJ, Creager MA. Aging progres-
sively impairs endothelium-dependent vasodilation in forearm resis-
tance vessels of humans. Hypertension 1996;27:849–53.
9. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated
coronary blood flow modulation in humans: effects of age, atheroscle-
rosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:
652–62.
0. Gennaro G, Menard C, Michaud SE, Rivard A. Age-dependent
impairment of reendothelialization after arterial injury: role of vascular
endothelial growth factor. Circulation 2003;107:230–3.
1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative
progenitor endothelial cells for angiogenesis. Science 1997;275:964–7.
2. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie
CM. Origin of endothelial progenitors in human postnatal bone
marrow. J Clin Invest 2002;109:337–46.
3. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging,
progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108:
457–63.
4. Scheubel RJ, Zorn H, Silber RE, et al. Age-dependent depression in
circulating endothelial progenitor cells in patients undergoing coronary
artery bypass grafting. J Am Coll Cardiol 2003;42:2073–80.
5. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating
endothelial progenitor cells by statin therapy in patients with stable
coronary artery disease. Circulation 2001;103:2885–90.
6. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor
cells, vascular function, and cardiovascular risk. N Engl J Med
2003;348:593–600.
7. Britten MB, Abolmaali ND, Assmus B, et al. Infarct Remodeling
After Intracoronary Progenitor Cell Treatment in Patients With
Acute Myocardial Infarction (TOPCARE-AMI): mechanistic in-
sights from serial contrast-enhanced magnetic resonance imaging.
Circulation 2003;108:2212–8.
8. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary
prevention of cardiovascular disease and stroke: 2002 update. Consen-
sus panel guide to comprehensive risk reduction for adult patients
without coronary or other atherosclerotic vascular diseases. Circulation
2002;106:388–91.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III). Executive sum-
mary of the third report of the National Cholesterol Education
Program (NCEP). JAMA 2001;285:2486–97.
0. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension 2003;42:1206–52.
1. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European
guidelines on cardiovascular disease prevention in clinical practice:
Third Joint Task Force of European and Other Societies on Cardio-
vascular Disease Prevention in Clinical Practice (constituted by rep-
resentatives of eight societies and by invited experts). Eur J Cardiovasc
Prev Rehabil 2003;10:S1–10.
2. Preik M, Lauer T, Heiss C, Tabery S, Strauer BE, Kelm M.
Automated ultrasonic measurement of human arteries for the deter-
mination of endothelial function. Ultraschall Med 2000;21:195–8.
3. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M.
Vascular effects of cocoa rich in flavan-3-ols. JAMA 2003;290:
1030–1.
4. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the
ultrasound assessment of endothelial-dependent flow-mediated vaso-
dilation of the brachial artery: a report of the International Brachial
Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257–65.
5. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo
expanded endothelial progenitor cells for therapeutic neovasculariza-
tion. Proc Natl Acad Sci USA 2000;97:3422–7.
22
2
2
3
3
3
3
3
3
3
3
3
3
1448 Heiss et al. JACC Vol. 45, No. 9, 2005
Progenitor Cell and Vascular Dysfunction With Age May 3, 2005:1441–86. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobili-
zation, differentiation, and homing. Arterioscler Thromb Vasc Biol
2003;23:1185–9.
7. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of
endothelial progenitor cells reduces neointima formation after vascular
injury. Circ Res 2003;93:e17–24.
8. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates
reendothelialization: a novel effect involving mobilization and incor-
poration of bone marrow-derived endothelial progenitor cells. Circu-
lation 2002;105:3017–24.
9. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D,
Robinson J, Deanfield JE. Aging is associated with endothelial
dysfunction in healthy men years before the age-related decline in
women. J Am Coll Cardiol 1994;24:471–6.
0. Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol
2003;31:659–72.
1. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with
alterations in vessel density, matrix composition, inflammatory re-
sponse, and growth factor expression. J Histochem Cytochem 2003;
51:1119–30.
2. Geiger H, Van Zant G. The aging of lympho-hematopoietic stem
cells. Nat Immunol 2002;3:329–33.3. Ross R. The pathogenesis of atherosclerosis: a perspective for the
1990s. Nature 1993;362:801–5.
4. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory
activity of circulating endothelial progenitor cells inversely correlate
with risk factors for coronary artery disease. Circ Res 2001;89:E1–7.
5. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial
progenitor cells from type II diabetics exhibit impaired proliferation,
adhesion, and incorporation into vascular structures. Circulation 2002;
106:2781–6.
6. Schmeisser A, Garlichs CD, Zhang H, et al. Monocytes coexpress
endothelial and macrophagocytic lineage markers and form cord-like
structures in Matrigel under angiogenic conditions. Cardiovasc Res
2001;49:671–80.
7. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC.
CD34 blood-derived human endothelial cell progenitors. Stem Cells
2001;19:304–12.
8. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S. Young adult bone
marrow-derived endothelial precursor cells restore aging-impaired
cardiac angiogenic function. Circ Res 2002;90:E89–93.
9. Murayama T, Kalka C, Silver M, Ma H, Asahara T. Aging impairs
therapeutic contribution of human endothelial progenitor cells to
postnatal neovascularization (abstr). Circulation 2001;104 Suppl II:
II68.
